APP and Alzheimer disease: Additionally, Zhou et al. developed glycosylated “triple-interaction” stabilized polymeric siRNA NPs (Gal-NP@siRNA) to target β-site amyloid precursor protein cleaving enzyme 1 (BACE1) in an amyloid precursor protein (APP)/PS1 transgenic AD mouse model [68].